Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CAH vs GSK✓SelectedUSD · GSKCAH vs GSK performance historyLatest closeAs of+1.06%11/13
Stock and ETF performance explorer

CAH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+37.7%
GSK return
+9.8%
Excess return
+27.9%
Maximum drawdown
-20.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%+0.5%+0.5%+0.9%
7D+3.5%+1.1%+2.3%+3.1%
30D+13.5%+6.3%+7.1%+11.4%
3M+21.8%+1.8%+20.0%+21.0%
6M+51.5%+1.7%+49.9%+50.2%
YTD+38.1%+6.5%+31.5%+38.9%
1Y+37.7%+9.5%+28.2%+38.4%
All+37.7%+9.8%+27.9%+38.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling